| 22-May-13 08:38AM | Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures PR Newswire -8.28% |
| 20-May-13 09:32AM | Law Offices of Todd M. Garber Announces Investigation of AVEO Pharmaceuticals, Inc. Business Wire |
| 17-May-13 02:34PM | Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO GlobeNewswire +7.12% |
| 01:15PM | Aveo Pharmaceuticals, Inc. Sued by Investor PR Newswire |
| 01:04PM | AVEO PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 15-May-13 06:05PM | InPlay: AVEO Pharma and Astellas announce presentations of tivozanib clinical data at 2013 ASCO Annual Meeting Briefing.com |
| 06:00PM | AVEO and Astellas Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting Business Wire |
| 04:46PM | Complete Seth Klarman And Baupost Group Portfolio Update at Seeking Alpha |
| 09:24AM | Aveo Screwed Up but Its Kidney Cancer Drug Is Real at TheStreet |
| 05:33AM | Tracking Seth Klarman's Baupost Group Holdings - Q1 2013 Update at Seeking Alpha |
| 14-May-13 09:02PM | The Law Offices of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. and Certain Officers -- (Nasdaq: AVEO) was filed on behalf of stockholders PR Newswire |
| 09:02PM | Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. Business Wire |
| 04:30PM | Abraham, Fruchter & Twersky, LLP Announces That a Class Action Lawsuit Has Been Filed against AVEO Pharmaceuticals, Inc. Business Wire |
| 13-May-13 05:29PM | SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment in AVEO Pharmaceuticals, Inc. to Contact Brower Piven Before the July 8, 2013 Lead Plaintiff Deadline -- AVEO GlobeNewswire |
| 04:04PM | Billionaire Seth Klarman's Long-Term Stock Picks at Seeking Alpha |
| 12:35PM | Seth Klarman's Worst Performing Stock Picks Year-To-Date at Seeking Alpha |
| 12-May-13 02:57PM | Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) Marketwired |
| 02:57PM | Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) Marketwire |
| 10-May-13 03:36PM | Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc. PR Newswire +5.79% |
| 09:08AM | AVEO PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09-May-13 09:40PM | 3 Health Care Stocks Under $10 to Watch at TheStreet |
| 07:10PM | Pomerantz Law Firm has filed a Class Action Against Aveo Pharmaceuticals, Inc. and Certain Officers -- AVEO GlobeNewswire |
| 11:00AM | Top Life Science Investors Of 2013 at Forbes |
| 07-May-13 03:38PM | Top Small-Cap Biotech Stocks Being Accumulated By Large Fund Managers at Seeking Alpha +5.13% |
| 06-May-13 01:03PM | Looking For Opportunity - 5 Biotechs That Crashed at Seeking Alpha -7.14% |
| 12:26PM | Fire Aveo's CEO for Incompetence and Arrogance Rivaling ImClone's Sam Waksal at TheStreet |
| 09:21AM | Leaders of TheStreet's Drug Approval Contest at TheStreet |
| 07:16AM | Zacks Bull and Bear of the Day Highlights: Private Bancorp, Pan American Silver, AVEO Pharmaceuticals, Astellas Pharma and Cleveland BioLabs Zacks |
| 05-May-13 04:00PM | Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players at Motley Fool |
| 07:00AM | 5 of Last Week's Biggest Losers at Motley Fool |
| 04-May-13 06:47PM | AVEO: Here's Looking At You, FDA at Seeking Alpha |
| 04:05PM | This Week in Biotech at Motley Fool |
| 10:29AM | 2 Biotechs To Avoid, 1 To Buy at Motley Fool |
| 07:00AM | The Best- And Worst-Performing Biotech Stocks, April 26 to May 3 at Forbes |
| 03-May-13 09:18PM | The ODAC Postmortem: Lessons Learned Part 1, AVEO at Seeking Alpha |
| 06:45PM | [video] You Ask, Cramer Answers! Buy Trius? at CNBC |
| 04:30PM | Negative Opinion on AVEO/ALPMY Candidate Zacks |
| 03:30PM | AVEO Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 03:04PM | Aveo Pharmaceuticals Gets Booed and 4 More Analyst Downgrades To Know at Wall St. Cheat Sheet |
| 08:50AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 08:30AM | Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aveo Pharmaceuticals, Inc. PR Newswire |
| 01:19AM | AVEO Pharma upgraded by Stifel Briefing.com |
| 02-May-13 07:14PM | An FDA Advisory Committee Kill Shot at Motley Fool -49.62% |
| 01-May-13 11:25AM | Finding Innovative Drugs that are Genuinely Differentiated and Not an Incremental Improvement is the Key to Biotech Success, According to Expert Analyst Boris Peaker Wall Street Transcript |
| 08:37AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 30-Apr-13 09:17PM | The FDA Firing Squad Takes Aim at Motley Fool -31.32% |
| 03:00PM | U.S. Stock Options With Biggest Changes in Implied Volatility at Bloomberg |
| 12:44PM | Why AVEO Pharmaceuticals Shares Imploded at Motley Fool |
| 12:40PM | AVEO Pharmaceuticals Enters Oversold Territory (AVEO) at TheStreet |
| 11:07AM | Should Aveo Run Second Study of Kidney Cancer Drug, FDA Asks at TheStreet |
| 10:22AM | RPT-UPDATE 1-FDA staff to ask expert panel if new trial needed for Aveo drug at Reuters |
| 10:08AM | UPDATE 1-FDA staff to ask expert panel if new trial needed for Aveo drug at Reuters |
| 09:20AM | FDA staff to ask expert panel if new trial needed for Aveo drug at Reuters |
| 09:14AM | Aveo down 20% after FDA posts briefing docs for cancer drug theflyonthewall.com |
| 09:12AM | Aveo Kidney Cancer Drug May Need More Study, FDA Says at Bloomberg |
| 09:10AM | Should Aveo Run Second Study of Kidney Cancer Drug, FDA Asks at TheStreet |
| 08:41AM | BRIEF-FDA staff ask if another study needed for Aveo cancer drug at Reuters |
| 29-Apr-13 02:06PM | Prepping for Aveo, Delcath FDA Panels at TheStreet |
| 12:36PM | An Oncology Stock to Watch at Motley Fool |
| 10:34AM | Cramer Says Sell Dell and Aveo, But Buy Buffalo Wild Wings and These 2 Stocks at Wall St. Cheat Sheet |
| 09:32AM | AVEO PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 09:25AM | AVEO Pharmaceuticals Earnings: Heres Why Shares are Down Now at Wall St. Cheat Sheet |
| 06:40AM | InPlay: AVEO Pharma misses by $0.01, misses on revs Briefing.com |
| 06:30AM | AVEO Reports First Quarter 2013 Financial Results Business Wire |
| 28-Apr-13 11:45AM | 2 FDA Decisions You Can't Afford to Miss This Week at Motley Fool |
| 05:07AM | Cramer's Mad Money - 16 Things To Watch In The Week Ahead (4/26/13) at Seeking Alpha |
| 26-Apr-13 06:45PM | Cramer's Homework Uncovers Stock Concerns at CNBC |
| 06:45PM | [video] You Ask, Cramer Answers! at CNBC |
| 08:15AM | Biotech Stock Mailbag: ASCO, Sarepta, Cel-Sci and Hate Mail! at TheStreet |
| 25-Apr-13 10:10AM | Aveo's Kidney Cancer Drug Won't Get FDA Panel OK at TheStreet -6.29% |
| 09:34AM | [video] Biotech's Next Big Thing: Aveo at TheStreet |
| 06:00AM | Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel at TheStreet |
| 24-Apr-13 10:34AM | Biotech's Next Big Thing: Aveo TheStreet.com TV |
| 10:08AM | Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval at Seeking Alpha |
| 08:30AM | Quickly Approaching Biopharma Catalyst Events at Seeking Alpha |
| 22-Apr-13 05:05PM | Aveo's Upcoming AdCom - Tivozanib's Safety Will Lead The Way Towards Approval at Seeking Alpha |
| 18-Apr-13 09:28AM | Thursday's BioPharma Trade Movers at Seeking Alpha |
| 16-Apr-13 07:55AM | AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential at Seeking Alpha |
| 02:18AM | Why We Expect The FDA To Approve Aveo's Tivozanib at Seeking Alpha |
| 14-Apr-13 03:44PM | 2 Oncology Biotechs For The Future at Seeking Alpha |
| 11-Apr-13 04:00PM | Biopharma CEO: You Really Get It When Youre Treating Your Own Son Off the Cuff |
| 10-Apr-13 11:46AM | 3 Biotech Stocks You Can't Ignore at Motley Fool |
| 05-Apr-13 03:58PM | 3 Healthcare Stocks Waiting For The FDA's Approval at Seeking Alpha |
| 02-Apr-13 02:36PM | 4 Health Care Stocks Under $10 to Watch at TheStreet |
| 06:52AM | Aveo Pharmaceuticals initiated with a Market Perform at JMP Securities theflyonthewall.com |
| 29-Mar-13 11:00AM | The Oncology Stock to Buy Today at Motley Fool |
| 27-Mar-13 08:50AM | 3 Small Cap Biopharmas Primed To Move Much Higher Now at Seeking Alpha |
| 22-Mar-13 07:35PM | 2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013 at Seeking Alpha |
| 20-Mar-13 01:11PM | Why AVEO Pharmaceuticals' Tivozanib Will Be Approved For The Treatment Of Advanced Renal Cell Carcinoma at Seeking Alpha |
| 04:00AM | Biopharma CEO: You Really Get It When Youre Treating Your Own Son Off the Cuff |
| 15-Mar-13 01:04PM | AVEO PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 14-Mar-13 10:16AM | Is AVEO's Tivozanib Any Better Than Placebo For The Treatment Of Renal Cell Carcinoma? at Seeking Alpha |
| 13-Mar-13 03:00PM | AVEO Pharmaceuticals, Inc. Presents at Barclays Global Healthcare Conference, Mar-13-2013 09:00 AM at Seeking Alpha |
| 12-Mar-13 08:00AM | Best And Worst FDA Drug Approval Stocks of 2013 at TheStreet |
| 11-Mar-13 05:19PM | AVEO PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online +6.79% |
| 06-Mar-13 05:33PM | Panel to Review AVEO/ALPMY's Drug Zacks |
| 06:30AM | AVEO Oncology to Present at the Barclays Global Healthcare Conference Business Wire |
| 27-Feb-13 03:36PM | AVEO to meet with FDA about tivozanib at bizjournals.com |
| 07:02AM | AVEO PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 06:34AM | Aveo Pharmaceuticals' NDA for tivozanib to be reviewed by FDA on May 2 at theflyonthewall.com |
